Dofetilide In Structural Heart Disease Overview Dofetilide, a class III antiarrhythmic drug, is approved for managing atrial fibrillation and atrial flutter, but it has also been used off-label to treat premature ventricular complexes (PVCs) and ventricular tachycardias (VTs). This study aimed to assess the
Tag: Ventricular tachycardia
Stellate Ganglion Block Success In Recurrent Ventricular Arrhythmias
Stellate Ganglion Block Success In Recurrent Ventricular Arrhythmias Overview One potential treatment for refractory ventricular arrhythmias is a stellate ganglion block (SGB). This study analyzed the effectiveness of SGB based on patient and arrhythmia characteristics, as well as predictors of success. Conducted across multiple
